United StatesLooks like things are going well in the US.
IRIS recently raised lots of money (well over $4 million, probably closer to $10 million):
https://ballastpointventures.com/2017/06/bpv-invests-in-pensacola-based-intelligent-retinal-imaging-systems/
IRIS is active in 28 states. Even AthenaHealth is using IRIS:
https://www.athenahealth.com/healthcare-technology-partners/clinical-device-integration/intelligent-retinal-imaging-systems
Diagnos signed a licensing agreement with IRIS in 2012, with a 3-year term, but there was no update after that.
In 2012, the press release said:
Intelligent Retina Imaging Systems (IRIS) will pay DIAGNOS $700,000 over a three year period. "We believe that our IRIS model, using CARA, is an excellent solution in helping to prevent vision loss in the diabetic population. We have the ability to preserve the vision of most, if not all, diabetic patients if we can treat them at the appropriate time." said Dr Sunil Gupta, President of IRIS.
If anyone knows about licensing agreements, I would like to hear their thoughts.